ACQUISITION OF HUMAN ALBUMIN 20 PERCENT, INJECTABLE 50 ML FOR THE PHARMACY SERVICE

This tender concerns the acquisition of Human Albumin 20 percent, injectable solution in 50 ml vials, intended for the Pharmacy Service. The contracting entity is the GOBIERNO REGIONAL DE JUNIN, specifically the HOSPITAL EL CARMEN, located in the JUNIN department. The procurement process is identified as ADS-CLASICO-20-2015-HRDMI -EC-1, utilizing the Selective Direct Award method of contracting. This implies a competitive bidding process where a select group of suppliers may be invited to submit proposals. The objective is to secure a supply of this critical pharmaceutical product for the hospital's needs. Human albumin is a vital component used in various medical treatments, including managing shock, burns, and liver disease, by helping to restore and maintain blood volume. The tender likely specifies detailed technical requirements for the albumin, such as purity, concentration, sterility, and packaging, to ensure it meets the highest medical standards. Interested parties should review the full tender documentation for precise specifications, eligibility criteria, submission deadlines, and evaluation procedures. The contract will be awarded based on the established criteria, ensuring the hospital receives a reliable supply of high-quality Human Albumin for patient care within the Junin region.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 57,000.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.